W. THOMAS GRANT II - 14 Nov 2023 Form 4 Insider Report for SelectQuote, Inc. (SLQT)

Role: Director
Signature: /s/ Daniel A. Boulware, Attorney-in-Fact
Issuer symbol: SLQT
Transactions as of: 14 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 16 Nov 2023, 19:44:15 UTC
Previous filing: 18 Sep 2023
Next filing: 14 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLQT	Common Stock, par value $0.01 per share	Options Exercise	$0	+203,125	+8.5%	$0.000000	2,596,594	14 Nov 2023	Direct
holding	SLQT	Common Stock, par value $0.01 per share						1,345,424	14 Nov 2023	By Self as Trustee for the W. Thomas Grant II Family Irrevocable Trust
holding	SLQT	Common Stock, par value $0.01 per share						355,760	14 Nov 2023	By Fidelity IRA
holding	SLQT	Common Stock, par value $0.01 per share						220,100	14 Nov 2023	By Frances D. Grant Trust	F1
holding	SLQT	Common Stock, par value $0.01 per share						35,601	14 Nov 2023	By Mainstar Trust IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLQT	Restricted Stock Units	Options Exercise	$0	-203,125	-100%	$0.000000^*	0	14 Nov 2023	Common Stock, par value $0.01 per share	203,125		Direct	F2, F3, F4
transaction	SLQT	Restricted Stock Units	Award	$0	+94,890		$0.000000	94,890	14 Nov 2023	Common Stock, par value $0.01 per share	94,890		Direct	F2, F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held indirectly by Mr. Grant in his capacity as Trustee of family trust.
F2	Represents restricted stock units of SelectQuote, Inc. (the "Company") granted to the recipient pursuant to the Company's 2020 Omnibus Incentive Plan.
F3	Each restricted stock unit represents a contingent right to receive one share of the Company's common stock, par value $0.01 per share.
F4	The award vested in full on the transaction date reported on this line.
F5	The award vests in full on the date of the Company's 2024 annual meeting of stockholders (the "Vesting Date"), subject to the recipient's continued service on the Board of Directors as of the Vesting Date.